Asia Pacific Peptide Synthesis Market Size & Outlook
- Biotechnology
- Proteomics & Protein Analysis
- Peptide Synthesis Market Outlook
- Proteomics & Protein Analysis
Global Market
Related Markets
Ask a question about the peptide synthesis market
Asia Pacific peptide synthesis market highlights
- The Asia Pacific peptide synthesis market generated a revenue of USD 203.5 million in 2024.
- The market is expected to grow at a CAGR of 9.3% from 2025 to 2033.
- In terms of segment, reagents & consumables was the largest revenue generating product in 2024.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 203.5 million |
| Market revenue in 2033 | USD 442.5 million |
| Growth rate | 9.3% (CAGR from 2025 to 2033) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Equipment |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Consumables, Equipment, Service |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GenScript, Bachem Holding AG, Biotage, Creative Diagnostics, PolyPeptide Group AG, Syngene, Lonza |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.2% of the global peptide synthesis market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 442.5 million by 2033.
Manufacturing is cheaper in the Asian Pacific countries than in developed Western countries. This reduced cost has made pharmaceutical companies view outsourcing the synthesis of peptides as a means of cutting unnecessary expenses, hence the increased demand for CMOs in the region. For instance, in October 2024, Latham & Watkins advised Metsera Inc., a clinical-stage biopharmaceutical company, in its strategic collaboration with Amneal Pharmaceuticals.
This partnership aims to develop and supply next-generation medicines for obesity and metabolic diseases. The collaboration leverages Metsera’s ultra-long-acting injectable and oral nutrient-stimulated hormone analogs, including its GLP-1 receptor agonist MET-097, which recently demonstrated promising Phase 1 clinical trial results. Such collaborations and cost advantages are expected to accelerate market growth further and solidify the Asia Pacific region’s position as a key hub for peptide synthesis.
No credit card required*
Publish Date: Jun 23, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Synthesis Market Scope
Peptide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| PolyPeptide Group AG | View profile | 1,273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | www.polypeptide.com |
| Bachem Holding AG | View profile | 2,006 | Hauptstrasse 144, Bubendorf, Switzerland, 4416 | www.bachem.com |
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | www.creative-diagnostics.com |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | www.syngeneintl.com |
| Biotage | View profile | 501-1000 | Uppsala, Uppsala Lan, Sweden, Europe | www.biotage.com |
| GenScript | View profile | - | - | - |
| Lonza | View profile | - | - | - |
Asia Pacific Peptide Synthesis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Peptide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Reagents & Consumables was the largest segment with a revenue share of 49.73% in 2024.
Horizon Databook has segmented the Asia Pacific peptide synthesis market based on reagents & consumables, equipment, service covering the revenue growth of each sub-segment from 2021 to 2033.
Manufacturing is cheaper in the Asian Pacific countries than in developed Western countries. This reduced cost has made pharmaceutical companies view outsourcing the synthesis of peptides as a means of cutting unnecessary expenses, hence the increased demand for CMOs in the region. For instance, in October 2024, Latham & Watkins advised Metsera Inc., a clinical-stage biopharmaceutical company, in its strategic collaboration with Amneal Pharmaceuticals.
This partnership aims to develop and supply next-generation medicines for obesity and metabolic diseases. The collaboration leverages Metsera’s ultra-long-acting injectable and oral nutrient-stimulated hormone analogs, including its GLP-1 receptor agonist MET-097, which recently demonstrated promising Phase 1 clinical trial results. Such collaborations and cost advantages are expected to accelerate market growth further and solidify the Asia Pacific region’s position as a key hub for peptide synthesis.
- Asia Pacific Peptide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Reagents & Consumables
- Equipment
- Service
- Asia Pacific Peptide Synthesis Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Asia Pacific Peptide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutics
- Research
- Diagnosis
- Asia Pacific Peptide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- CDMOs & CROs
- Academic & Research Institutes
Reasons to subscribe to Peptide Synthesis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Peptide Synthesis Market Outlook databook
- Our clientele includes a mix of Peptide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Peptide Synthesis Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Peptide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Peptide Synthesis Market, 2021-2033 (US$M)
Asia Pacific peptide synthesis market statistics, by product, 2021-2033 (US$M)
